Zoekresultaten - Portaal voor medische datamodellen (MDM-portaal)

Zoekresultaten filteren
Datamodellen selecteren

Geselecteerde datamodellen

U moet ingelogd zijn om meerdere datamodellen te selecteren en die te downloaden of te analyseren.

3 Zoekresultaten.

Genetic Screening For HLA-B5701 n Patients with HIV Day 1 NCT00340080 - Genetic Screening For HLA-B5701 Day 1 NCT00340080

- 20-06-17 - 1 Formulier, 1 Itemgroep, 12 Data-elementen, 1 Taal

Itemgroep: Day 1

NCT00340080 / VIIV-CNA106030 https://clinicaltrials.gov/ct2/show/NCT00340080 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Day 1 (Cohort Study) Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Genetic Screening For HLA-B5701 in Patients with HIV Inclusion and Exclusion Criteria NCT00340080 - Genetic Screening For HLA-B5701 Inclusion and Exclusion Criteria NCT00340080

- 19-04-17 - 1 Formulier, 1 Itemgroep, 5 Data-elementen, 1 Taal

Itemgroep: Inclusion and Exclusion Criteria

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Inclusion and Exclusion Criteria Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Genetic Screening For HLA-B5701 in Patients with HIV Day 1 NCT00340080 - Genetic Screening For HLA-B5701 Day 1 NCT00340080

- 19-04-17 - 1 Formulier, 1 Itemgroep, 17 Data-elementen, 1 Taal

Itemgroep: Day 1 (Baseline)

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Day 1 (Baseline) Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.